Solventum Corporation vs Johnson & Johnson
SOLV vs JNJ — side-by-side comparison from reported financials. SOLV leads 4, JNJ leads 6 of 10 comparable metrics.
Solventum Corporation
SOLV · Healthcare
$87.88+1.70%Strained
Johnson & Johnson
JNJ · Healthcare
$261.79+2.07%Mixed
| Metric | SOLV | JNJ |
|---|---|---|
| Price | $87.88 | $261.79 |
| Market cap | $15.0B | $631B |
| Revenue (TTM) | $8.31B | $97.9B |
| Revenue growth | +0.8% | +5.6% |
| Net margin | 17.3% | 21.5% |
| Free cash flow | -$118M | $22.2B |
| Net cash (debt) | ($4.16B) | ($27.8B) |
| 1-year price return | +22.4% | +37.0% |
| P/E | 10.4 | 29.9 |
| P/E vs own history (cheap-side %) | 66% | 16% |
| Dividend yield | — | 2.00% |
| Return on equity | 29% | 26% |
| CV checks passed | 6 of 10 | 10 of 10 |
| Employees | 20,000 | 140,800 |
Full résumé-style profiles: SOLV CV · JNJ CV
Green marks the stronger side on comparable metrics. Figures are derived from company filings and may be delayed, restated or incomplete — information, not investment advice.